Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2020 13:53 ET | Source: ORPHAZYME A/S

Orphazyme files registration statement in the U.S. in connection with proposed global offering, consisting of initial public offering of ADSs in the U.S. and concurrent private placement of ordinary shares in Europe

Orphazyme A/SCompany announcement No. 49/2020 ...
September 01, 2020 12:15 ET | Source: ORPHAZYME A/S

Capital increase of 1,927 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units

Orphazyme A/SCompany announcement No. 48/2020 ...
September 01, 2020 12:07 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
August 28, 2020 04:45 ET | Source: ORPHAZYME A/S

Notice to convene Extraordinary General Meeting in Orphazyme A/S

Orphazyme A/SCompany announcement No....
August 28, 2020 01:00 ET | Source: ORPHAZYME A/S

Orphazyme announces Interim Report First Half 2020

Company announcementNo. 45/2020 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N CVR No.: 32266355 Copenhagen, Denmark, August 28, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage...
August 26, 2020 03:47 ET | Source: ORPHAZYME A/S

Orphazyme Interim Report First Half 2020 Presentation

Orphazyme A/SInvestor news No....
July 31, 2020 07:46 ET | Source: ORPHAZYME A/S

Capital increase of 31,250 shares in Orphazyme A/S as a result of vesting and exercise of Matching Shares

Orphazyme A/SCompany announcement No....
July 29, 2020 08:51 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
July 20, 2020 01:48 ET | Source: ORPHAZYME A/S

Orphazyme completes rolling submission of New Drug Application to U.S. FDA for arimoclomol for Niemann-Pick disease Type C

Orphazyme A/SInvestor News No. 05/2020 ...
July 17, 2020 02:25 ET | Source: ORPHAZYME A/S

Orphazyme to collaborate with The Michael J. Fox Foundation on Parkinson’s disease research

Orphazyme A/SInvestor News No....